Company

Merck KGaA Launches Uptune Program in Asia, Offers Startups Up to €100,000

CompanyDrug

Pfizer Launches Cejemly in China for Stage III NSCLC, Expands Immunotherapy Reach

CompanyDeals

Sihuan Pharma to Sell Generic Drug Businesses, Shift Focus to Aesthetics and Biologics

CompanyDrug

Luye Pharma’s Lurbinectedin Receives Hainan Approval for SCLC Treatment

CompanyDrug

Novartis’ Aimovig Launches in China via GBA Early Access Scheme for Migraine Treatment

Drug

CStone Pharmaceuticals’ Gavreto Wins Hong Kong Approval for RET Fusion NSCLC

CompanyMedical Device

NMPA Approves RocketHeart’s LV Assist System and Our United Group’s Radiation Therapy Device

CompanyDeals

Ping An Good Doctor Partners with China Biotech Services for Cancer Testing and BNCT Treatment

CompanyDrug

Kelun Pharma’s SKB264 ADC Receives NMPA Green Light for Phase II Solid Tumor Study

CompanyDrug

Luye Pharma Initiates Phase III Study of Trulicity Biosimilar BA5101 in China

CompanyDeals

Shanghai Electric and Siemens Partner on Localization of High-End Medical Equipment

CompanyDrug

Beijing Science Sun’s LZ901 Shingles Vaccine Receives FDA IND Approval